Manufacturing Sources Clause Samples
The Manufacturing Sources clause defines the requirements and restrictions regarding where and by whom a product or its components may be manufactured. Typically, this clause specifies approved manufacturers, geographic locations, or standards that must be met, and may require the contracting party to disclose or seek approval for any changes to manufacturing sources. Its core function is to ensure quality control, supply chain transparency, and compliance with regulatory or contractual obligations, thereby reducing risks related to unauthorized production or substandard materials.
Manufacturing Sources. To maintain delivery schedules, Seller reserves the right to have all or any part of the Buyer's order manufactured at any of Sellers', sellers' licensees or sub contractors' plants, globally.
Manufacturing Sources. SMI represents that, as of the Effective Date, it has a fully certified and functioning ISO 9000 manufacturing source for the Modified Starch. In addition, SMI represents that, as of the Effective Date, its sources of raw materials used in the Modified Starch are ISO certified sources that would allow SMI to manufacture the Modified Starch as required by CryoLife.
4.3.1 SMI agrees to maintain such manufacturing source or procure other sources, facilities and/or equipment in order to replace such manufacturing source that are reasonably acceptable to CryoLife and meet ISO 13485 requirements in the event that SMI’s then-active manufacturing facility becomes unable or unwilling to supply Modified Starch in a timely manner.
4.3.2 SMI shall have an approved second source for Modified Starch within thirty-six (36) months from the Effective Date of this License Agreement. Further, SMI will grant CryoLife an option, for a period of thirty-six (36) months from the Effective Date of this License Agreement, to acquire the full Modified Starch production technology for a negotiated sum not to exceed One Million U.S. dollars ($1,000,000.00).
Manufacturing Sources. SMI represents that, as of the Effective Date, it has a fully CE Marking certified and functioning manufacturing source for the Products capable of producing sufficient Product to meet CryoLife’s needs under this Agreement. SMI agrees to maintain such manufacturing source or procure other sources, facilities and/or equipment in order to replace such manufacturing source that are reasonably acceptable to CryoLife and CE Marking certified in the event that SMI’s then-active manufacturing facility becomes unable or unwilling to supply Products in a timely manner. SMI further agrees to establish a second CE Marking certified and fully functioning manufacturing facility for Products that is reasonably acceptable to CryoLife on or before December 31, 2012.
Manufacturing Sources. To maintain delivery schedules, Seller reservplants on a world-wide basis.
Manufacturing Sources. Unless otherwise agreed in writing by Somanetics and CORrestore, during the term of the Licenses, Somanetics shall engage St. Jude Medical, Edwa▇▇▇ ▇▇▇e Sciences, Inc., Medtronic, Bio Vascular, Shelhigh, PM Devices, Inc., one of their affiliates or any combination of the foregoing (collectively, the "Manufacturers"), to manufacture the Products.